Gene · 5873
Papers3,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 3,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rab27b, a Regulator of Exosome Secretion, Is Associated With Peritoneal Metastases in Gastric Cancer. | Cancer Genomics Proteomics | 2023 | 36581340 | PubTator, text mining | PubMed |
| Identification of Small GTPases That Phosphorylate IRF3 through TBK1 Activation Using an Active Mutant Library Screen. | Biomol Ther (Seoul) | 2023 | 36579460 | PubTator, text mining | PubMed |
| Extracellular vesicles in the glioblastoma microenvironment: A diagnostic and therapeutic perspective. | Mol Aspects Med | 2023 | 36577547 | PubTator, text mining | PubMed |
| Autoimmune Neutropenias: Update on Clinical and Biological Features in Children and Adults. | Hemasphere | 2023 | 36570693 | PubTator, text mining | PubMed |
| Manipulation of PD-L1 Endosomal Trafficking Promotes Anticancer Immunity. | Adv Sci (Weinh) | 2023 | 36567273 | PubTator, text mining | PubMed |
| Proximity proteomics identifies septins and PAK2 as decisive regulators of actomyosin-mediated expulsion of von Willebrand factor. | Blood | 2023 | 36564030 | PubTator, text mining | PubMed |
| Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity. | J Allergy Clin Immunol | 2023 | 36522221 | PubTator, text mining | PubMed |
| The impact of environmental contaminants on extracellular vesicles and their key molecular regulators: A literature and database-driven review. | Environ Mol Mutagen | 2023 | 36502378 | PubTator, text mining | PubMed |
| Impact of Genetic Diagnosis on the Outcome of Hematopoietic Stem Cell Transplant in Primary Immunodeficiency Disorders. | J Clin Immunol | 2023 | 36495401 | PubTator, text mining | PubMed |
| Peroxisome proliferator-activated receptor γ coactivator 1-α overexpression improves angiogenic signalling potential of skeletal muscle-derived extracellular vesicles. | Exp Physiol | 2023 | 36454193 | PubTator, text mining | PubMed |
| Evaluation of CRISPR/Cas9 exon-skipping vector for choroideremia using human induced pluripotent stem cell-derived RPE. | J Gene Med | 2023 | 36413603 | PubTator, text mining | PubMed |
| Dysfunctional subsets of CD39+ T cells, distinct from PD-1+, driven by leukemic extracellular vesicles in myeloid leukemias. | Haematologica | 2023 | 36384249 | PubTator, text mining | PubMed |
| The imminent role of microRNAs in salivary adenoid cystic carcinoma. | Transl Oncol | 2023 | 36335706 | PubTator, text mining | PubMed |
| Chloride Channel-3 (ClC-3) Modifies the Trafficking of Leucine-Rich Repeat-Containing 8A (LRRC8A) Anion Channels. | J Membr Biol | 2023 | 36322172 | PubTator, text mining | PubMed |
| Enhancing the Cellular Production of Extracellular Vesicles for Developing Therapeutic Applications. | Pharm Res | 2023 | 36319886 | PubTator, text mining | PubMed |
| LC3-dependent EV loading and secretion (LDELS) promotes TFRC (transferrin receptor) secretion via extracellular vesicles. | Autophagy | 2023 | 36286616 | PubTator, text mining | PubMed |
| MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity. | Blood Adv | 2023 | 36206192 | PubTator, text mining | PubMed |
| Tumor-Derived Extracellular Vesicles: Multifunctional Entities in the Tumor Microenvironment. | Annu Rev Pathol | 2023 | 36202098 | PubTator, text mining | PubMed |
| Retinal organoids provide unique insights into molecular signatures of inherited retinal disease throughout retinogenesis. | J Anat | 2023 | 36177499 | PubTator, text mining | PubMed |
| Cancer as an infective disease: the role of EVs in tumorigenesis. | Mol Oncol | 2023 | 36168102 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5873/papers?page=30